Literature DB >> 8097006

Childbearing, oral contraceptive use, and breast cancer.

V Beral, G Reeves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8097006     DOI： 10.1016/0140-6736(93)92469-a

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Authors:  Nadine Andrieu; David E Goldgar; Douglas F Easton; Matti Rookus; Richard Brohet; Antonis C Antoniou; Susan Peock; Gareth Evans; Diana Eccles; Fiona Douglas; Catherine Noguès; Marion Gauthier-Villars; Agnès Chompret; Flora E Van Leeuwen; Irma Kluijt; Javier Benitez; Brita Arver; Edith Olah; Jenny Chang-Claude
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.

Authors:  Annekatrin Lukanova; Helja-Marja Surcel; Eva Lundin; Marjo Kaasila; Hans-Ake Lakso; Helena Schock; Anika Husing; Rudolf Kaaks; Pentti Koskela; Kjell Grankvist; Eero Pukkala; Anne Zeleniuch-Jacquotte; Matti Lehtinen; Paolo Toniolo
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

3.  The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.

Authors:  Kimberly Kelly; Howard Leventhal; Michael Andrykowski; Deborah Toppmeyer; Judie Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  J Genet Couns       Date:  2004-06       Impact factor: 2.537

4.  The utility of web mining for epidemiological research: studying the association between parity and cancer risk.

Authors:  Georgia Tourassi; Hong-Jun Yoon; Songhua Xu; Xuesong Han
Journal:  J Am Med Inform Assoc       Date:  2015-11-27       Impact factor: 4.497

5.  The present and the future of breast cancer burden in the Kingdom of Saudi Arabia.

Authors:  Ezzeldin M Ibrahim; Ahmed A Zeeneldin; Bakr Bin Sadiq; Adnan A Ezzat
Journal:  Med Oncol       Date:  2008-03-04       Impact factor: 3.064

6.  Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Authors:  Julie Lecarpentier; Catherine Noguès; Emmanuelle Mouret-Fourme; Marion Gauthier-Villars; Christine Lasset; Jean-Pierre Fricker; Olivier Caron; Dominique Stoppa-Lyonnet; Pascaline Berthet; Laurence Faivre; Valérie Bonadona; Bruno Buecher; Isabelle Coupier; Laurence Gladieff; Paul Gesta; François Eisinger; Marc Frénay; Elisabeth Luporsi; Alain Lortholary; Chrystelle Colas; Catherine Dugast; Michel Longy; Pascal Pujol; Julie Tinat; Rosette Lidereau; Nadine Andrieu
Journal:  Breast Cancer Res       Date:  2012-07-03       Impact factor: 6.466

7.  Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Authors:  Antonis C Antoniou; Andrew Shenton; Eamonn R Maher; Emma Watson; Emma Woodward; Fiona Lalloo; Douglas F Easton; D Gareth Evans
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

8.  Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.

Authors:  I dos Santos Silva; A J Swerdlow
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Authors:  Laufey Tryggvadottir; Elinborg J Olafsdottir; Sigfridur Gudlaugsdottir; Steinunn Thorlacius; Jon G Jonasson; Hrafn Tulinius; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2003-06-24       Impact factor: 6.466

10.  Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.

Authors:  H Jernström; T Sandberg; E Bågeman; A Borg; H Olsson
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.